Psoriasis Treatment Market Share
ID: MRFR/Pharma/2052-HCR
200 Pages
October 2025
Psoriasis Treatment Market Size, Growth Research Report By Treatment Type (Topical Treatments, Systemic Treatments, Phototherapy, Biologics), By Administration Route (Oral, Topical, Injectable, Intravenous), By Indication (Plaque Psoriasis, Guttate Psoriasis, Inverse Psoriasis, Pustular Psoriasis), By End User (Hospital, Dermatology Clinics, Homecare Settings) and By Regional (North America, Eu...
Market Summary
As per Market Research Future Analysis, the Global Psoriasis Treatment Market was valued at 19.12 USD Billion in 2024 and is projected to grow to 0.00 USD Billion by 2035, with a CAGR of 0.00% from 2025 to 2035. The market is driven by the increasing prevalence of psoriasis, advancements in treatment options, and rising healthcare expenditure globally.
Key Market Trends & Highlights
Key trends driving the Psoriasis Treatment Market include advancements in treatment options and increasing awareness.
- Psoriasis affects approximately 125 million individuals globally, representing 2% to 3% of the world's population. Biologics are projected to grow from 2.65 USD Billion in 2024 to 3.8 USD Billion by 2035. Topical Treatments are expected to rise from 2.0 USD Billion in 2024 to 3.2 USD Billion by 2035. North America is anticipated to reach 4.5 USD Billion by 2035, leading the market.
Market Size & Forecast
| 2024 Market Size | USD 19.12 Billion |
| 2035 Market Size | USD 0.00 Billion |
| CAGR (2025-2035) | 0.00% |
| Largest Regional Market Share in 2024 | North America. |
Major Players
<p>Key players include Pfizer, Merck and Co, AbbVie, Johnson & Johnson, and Novartis.</p>
Market Trends
The Psoriasis Treatment market is growing due to key market drivers within it. This growth is due to the increasing awareness concerning psoriasis which, along with its prevalence in numerous regions, prompts the demand for effective treatment options. Moreover, newer therapies are being developed and becoming more accessible due to improvements in biotechnology and pharmacology. There has been a change in treatment approaches, as moderate to severe cases of psoriasis are now treated using Biologics and targeted therapies, which are more effective and gaining greater popularity than before.
With new developments in telehealth and other digital health solutions, there is a greater focus on caring for the patients, which has uncovered new opportunities for the market.
This development enables more efficient patient management and treatment adherence, improving results for patients with psoriasis. Furthermore, recent partnerships between pharmaceutical companies and health care providers focus on developing new research and treatment solutions, leveraging networked care to fulfill existing medical gaps. Regarding new developments, there has been a marked increase in attention and funding directed toward psoriasis research, particularly in exploring the disease and its comorbidities. The increase in skin health dietary supplements and natural treatment approaches is expanding as more patients look for alternative ways to cope with their disease.
The international scope of the market implies that policy makers and regulatory bodies in different areas of the world are also influencing the treatment landscape, promising more active innovative therapy development while ensuring patient safety. All in all, these trends demonstrate a responsive and proactive market geared toward addressing the needs of patients and health care practitioners across the globe.
<p>The increasing prevalence of psoriasis, coupled with advancements in biologic therapies, suggests a transformative shift in treatment paradigms that may enhance patient outcomes and quality of life.</p>
National Institutes of Health
Psoriasis Treatment Market Market Drivers
Market Growth Projections
The Global Psoriasis Treatment Market Industry is poised for substantial growth, with projections indicating a market value of 7.45 USD Billion in 2024 and an anticipated increase to 12 USD Billion by 2035. This growth trajectory reflects a compound annual growth rate of 4.43% from 2025 to 2035. Factors such as rising prevalence, advancements in treatment options, and increased healthcare expenditure contribute to this positive outlook. The market's expansion is likely to be driven by continuous innovation and the introduction of new therapies, catering to the diverse needs of patients suffering from psoriasis.
Rising Prevalence of Psoriasis
The increasing prevalence of psoriasis globally is a primary driver of the Global Psoriasis Treatment Market Industry. It is estimated that around 125 million people worldwide are affected by this chronic skin condition. This growing patient population necessitates the development and availability of effective treatment options. As awareness of psoriasis rises, more individuals seek medical attention, contributing to market growth. The Global Psoriasis Treatment Market is projected to reach 7.45 USD Billion in 2024, reflecting the urgent need for innovative therapies and management strategies to address this widespread health issue.
Growing Awareness and Education
The rise in awareness and education regarding psoriasis plays a pivotal role in shaping the Global Psoriasis Treatment Market Industry. Initiatives by healthcare organizations and advocacy groups aim to educate the public about the condition, its symptoms, and available treatments. This heightened awareness encourages individuals to seek medical advice and treatment, leading to earlier diagnosis and intervention. As more people become informed about psoriasis, the demand for effective therapies is likely to increase. This trend aligns with the projected market growth, as the industry adapts to meet the needs of a more educated patient population.
Increased Healthcare Expenditure
Rising healthcare expenditure across various regions is a crucial factor propelling the Global Psoriasis Treatment Market Industry. As governments and private sectors allocate more funds towards healthcare, patients gain better access to dermatological services and psoriasis treatments. This trend is particularly evident in developed nations, where healthcare budgets are expanding to accommodate chronic disease management. The increasing investment in healthcare infrastructure supports the availability of advanced treatment options, thereby enhancing patient outcomes. Consequently, the market is expected to experience a compound annual growth rate of 4.43% from 2025 to 2035, reflecting the positive impact of increased healthcare spending.
Advancements in Treatment Options
Innovations in treatment modalities significantly influence the Global Psoriasis Treatment Market Industry. Recent developments include biologics, systemic therapies, and topical treatments that have shown promising results in managing psoriasis symptoms. For instance, biologics targeting specific immune pathways have transformed treatment approaches, offering patients more effective and personalized options. As these therapies gain regulatory approval and become more accessible, they are likely to drive market expansion. The anticipated growth trajectory suggests that the market could reach 12 USD Billion by 2035, indicating a robust demand for advanced treatment solutions.
Regulatory Support for New Treatments
Regulatory bodies' support for the approval of new psoriasis treatments significantly impacts the Global Psoriasis Treatment Market Industry. Streamlined approval processes and incentives for developing innovative therapies encourage pharmaceutical companies to invest in research and development. This regulatory environment fosters the introduction of novel treatment options, enhancing competition within the market. As new therapies receive approval, they provide patients with more choices, potentially improving treatment outcomes. The ongoing regulatory support is expected to sustain market growth, contributing to the overall expansion of the industry.
Market Segment Insights
Psoriasis Treatment Market Treatment Type Insights
<p>The Global Psoriasis Treatment Market exhibits significant growth within the Treatment Type segment, where the valuations for various treatment methods highlight the diverse approaches to managing this chronic skin condition. In 2024, the Global Psoriasis Treatment Market revenue reach approximately 7.45 USD Billion, with substantial contributions from its various treatment categories. As an effective measure for mild to moderate psoriasis, Topical Treatments are valued at 2.0 USD Billion in 2024 and projected to rise to 3.2 USD Billion by 2035, indicating consistency in their demand due to their accessibility and ease of use.</p>
<p>Systemic Treatments, which are often reserved for more severe cases, represent a notable segment as well, beginning at a valuation of 1.8 USD Billion in 2024 and expected to grow to 3.0 USD Billion by 2035. The effectiveness of these treatments in providing relief from more intense symptoms contributes to their importance in the market.</p>
<p>Phototherapy, another essential treatment option, is valued at 1.0 USD Billion in 2024 with expectations to double this value to 2.0 USD Billion by 2035, reflecting its role as a viable treatment for patients who prefer non-pharmaceutical options or require combination therapies.Biologics lead this market segment with a projection starting value of 2.65 USD Billion in 2024, increasing to 3.8 USD Billion by 2035; this category's biologic drugs showcase remarkable efficacy in targeting specific pathways in immune response, thereby offering significant benefits for moderate to severe psoriasis patients. </p>
Psoriasis Treatment Market Administration Route Insights
<p>The Administration Route segment of the Global Psoriasis Treatment Market plays a crucial role in determining how therapies are delivered to patients suffering from this chronic skin condition. As the Global Psoriasis Treatment Market revenue is expected to reach 7.45 billion USD , the market is largely driven by the efficiency and convenience of various administration routes. Among the different methods, topical treatments are widely adopted due to their ease of use and direct application to affected areas, making them particularly significant in managing mild to moderate psoriasis.</p>
<p>Oral therapies are also gaining traction, primarily for their systemic effect and patient preference for non-invasive treatment options. Injectable therapies, often considered for more severe cases, offer rapid action and potent effects, while intravenous administration is utilized for patients requiring immediate therapeutic interventions. The choice of administration routes is influenced by factors such as patient compliance, the severity of the disease, and the healthcare setting, contributing to the overall market growth and dynamics. </p>
<p>As the Global Psoriasis Treatment Market statistics show, these varied routes facilitate better management and enhance patient outcomes, indicating a healthy evolution in treatment approaches.</p>
Psoriasis Treatment Market Indication Insights
<p>The Global Psoriasis Treatment Market valued at 7.45 USD Billion in 2024, with a significant emphasis on the various indicatives of psoriasis. This market comprises diverse types of psoriasis, including Plaque, Guttate, Inverse, and Pustular Psoriasis, each representing distinct manifestations of the condition. Plaque Psoriasis, being the most prevalent form, dominates the market due to its widespread occurrence and the chronic nature that requires ongoing treatment intervention. </p>
<p>Guttate Psoriasis is another notable form often triggered by infections, making it significant in market consideration as it presents unique treatment challenges.Inverse Psoriasis, characterized by red, shiny lesions in skin folds, showcases a crucial segment due to its specific management needs. Pustular Psoriasis, though less common, highlights the necessity for targeted therapies, further shaping the market landscape. </p>
<p>The growth of the Global Psoriasis Treatment Market is propelled by advancements in treatment modalities and an increasing focus on patient-centered care, providing abundant opportunities for stakeholders to innovate while addressing pressing challenges. With diverse segments addressing varied patient profiles, the market is poised for evolution, driven by ongoing Research and Development efforts.</p>
Psoriasis Treatment Market End User Insights
<p>The Global Psoriasis Treatment Market is poised for notable growth, expected to reach a valuation of 7.45 USD Billion . This market's segmentation includes critical areas such as hospitals, dermatology clinics, and homecare settings, with each playing a vital role in patient care. Hospitals serve a high volume of patients requiring advanced treatment options, making them a dominant force within the market. Dermatology clinics provide specialized care, leading to tailored treatments for individuals, thereby enhancing the effectiveness of therapies selected for specific patient needs.</p>
<p>Homecare settings are increasingly significant due to their convenience and the rising patient preference for treatments that can be administered in their own environments, significantly impacting patient adherence. The Global Psoriasis Treatment Market data reflects ongoing trends towards personalized medicine and the expanding role of telemedicine, providing opportunities to enhance care access. Furthermore, the aging global population, increasing incidence of psoriasis, and ongoing Research and Development efforts are fundamental growth drivers throughout this market.</p>
<p>However, challenges such as treatment costs and patient access remain pertinent as market stakeholders navigate the evolving healthcare landscape. Understanding these segments and their interdependencies is essential for leveraging existing opportunities and addressing challenges in the Global Psoriasis Treatment Market industry.</p>
Get more detailed insights about Psoriasis Treatment Market Research Report - Forecast till 2035
Regional Insights
The Global Psoriasis Treatment Market showcases significant regional diversity with North America dominating the landscape. In 2024, North America holds a valuation of 2.85 USD Billion, growing to 4.5 USD Billion by 2035, marking it as a substantial contributor to the market growth. Europe follows closely, with a valuation of 2.25 USD Billion in 2024 and projected to reach 3.5 USD Billion by 2035, indicating a strong market presence.
The Asia-Pacific (APAC) region is also noteworthy, valued at 1.75 USD Billion in 2024, with expectations to rise to 2.5 USD Billion in 2035, reflecting growing demand for psoriasis treatment options in emerging markets.
South America, though smaller, is on an upward trajectory with a value of 0.45 USD Billion in 2024, anticipated to grow to 0.7 USD Billion by 2035. The Middle East and Africa (MEA) region currently holds a value of 0.15 USD Billion in 2024, expected to double by 2035, showing gradual market development. Factors supporting this regional segmentation include increasing healthcare access, rising prevalence of psoriasis, and a growing awareness of treatment options among consumers.
Each region's unique healthcare infrastructure and market needs present distinct opportunities for growth in the Global Psoriasis Treatment Market.The varied market statistics across regions underscore the importance of targeting specific regional strategies to optimize outreach and product availability.
Key Players and Competitive Insights
The Global Psoriasis Treatment Market has become increasingly competitive, driven by the rising prevalence of psoriasis and growing awareness among healthcare providers and patients about the effectiveness of various treatment options. The market has seen a surge in the development of innovative therapies, including biologics, systemic treatments, and topical applications, aimed at providing effective relief for patients suffering from this chronic skin condition.
Competition among key players in this market is characterized by the continuous introduction of novel products, strategic partnerships, and aggressive marketing strategies to capture larger market shares. The dynamic nature of the industry is further influenced by advancements in research and technology, which have enabled faster identification and targeting of new therapeutic pathways, ultimately benefiting patients looking for improved treatment modalities.
Pfizer has established a strong presence in the Global Psoriasis Treatment Market through its innovative treatment options that address the diverse needs of psoriasis patients. The company has successfully leveraged its research capabilities to develop effective biologics that have gained significant traction in the market. Pfizer's strengths lie in its extensive portfolio, robust clinical data supporting its products, and a dedicated focus on improving patient outcomes. The company's commitment to ongoing research and development ensures the continuous evolution of its treatment offerings, allowing it to respond effectively to the changing market dynamics and patient requirements.
Pfizer's strategic collaborations and partnerships further bolster its market position, allowing for streamlined distribution and enhanced market access across various regions.
Merck and Co has made significant inroads into the Global Psoriasis Treatment Market, recognized for its innovative therapies designed to tackle the challenges associated with this skin disease. The company boasts an impressive lineup of key products that include both biologics and oral medications specifically tailored for psoriasis treatment. Merck and Co's strengths stem from its strong research foundation and ongoing focus on clinical trials that demonstrate the efficacy and safety of its products.
The company's ability to adapt to changing market conditions is evident in its strategic mergers and acquisitions that bolster its product portfolio and enhance its market footprint.
These efforts, combined with its relentless commitment to patient-centric approaches, have positioned Merck and Co as a formidable player in the Global Psoriasis Treatment Market, ensuring a competitive edge through continuous innovation and widespread geographical reach.
Key Companies in the Psoriasis Treatment Market market include
Industry Developments
In recent months, the Global Psoriasis Treatment Market has experienced significant developments, particularly with companies like AbbVie making strides in Research and Development for improved biologic therapies. In September 2023, Pfizer launched a new clinical trial aimed at exploring innovative treatments for moderate to severe psoriasis, showcasing ongoing commitment in this sector. Similarly, in August 2023, Merck announced advancements in their psoriasis portfolio, aimed at enhancing patient outcomes.
Major companies including Johnson and Johnson and Novartis continue to engage in improving treatment options, while GSK has been actively investing in research to tap into emerging treatment modalities. In terms of mergers and acquisitions, in July 2023, AstraZeneca completed the acquisition of a portfolio from a small biotech company focused on skin diseases, significantly enhancing their capabilities in the psoriasis market.
Reports indicate that there is growing momentum for biologic therapies, which has led to increased valuations for key players in the market. Over the past two to three years, the industry has witnessed a marked increase in interest and investment, particularly in targeting more effective treatment options for patients, as the demand for innovative solutions continues to rise globally.
Future Outlook
Psoriasis Treatment Market Future Outlook
<p>The Global Psoriasis Treatment Market is projected to grow at a 4.43% CAGR from 2024 to 2035, driven by advancements in biologics, increasing prevalence, and rising awareness.</p>
New opportunities lie in:
- <p>Develop targeted therapies for specific psoriasis subtypes to enhance treatment efficacy. Leverage telemedicine platforms for remote patient monitoring and personalized treatment plans. Invest in patient education programs to improve adherence and treatment outcomes.</p>
<p>By 2035, the market is expected to exhibit robust growth, reflecting advancements in treatment options and increased patient access.</p>
Market Segmentation
Psoriasis Treatment Market End User Outlook
- {""=>["Hospital"
- "Dermatology Clinics"
- "Homecare Settings"]}
Psoriasis Treatment Market Regional Outlook
- {""=>["North America"
- "Europe"
- "South America"
- "Asia Pacific"
- "Middle East and Africa"]}
Psoriasis Treatment Market Indication Outlook
- {""=>["Plaque Psoriasis"
- "Guttate Psoriasis"
- "Inverse Psoriasis"
- "Pustular Psoriasis"]}
Psoriasis Treatment Market Treatment Type Outlook
- {""=>["Topical Treatments"
- "Systemic Treatments"
- "Phototherapy"
- "Biologics"]}
Psoriasis Treatment Market Administration Route Outlook
- {""=>["Oral"
- "Topical"
- "Injectable"
- "Intravenous"]}
Report Scope
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2023 | 7.14(USD Billion) |
| MARKET SIZE 2024 | 7.45(USD Billion) |
| MARKET SIZE 2035 | 12.0(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 0.00% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2023 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Pfizer, Merck and Co, AbbVie, Johnson and Johnson, Lilly, GSK, UCB, Celgene, Novartis, Regeneron Pharmaceuticals, BristolMyers Squibb, AstraZeneca, Amgen, Eli Lilly and Company, Sanofi |
| SEGMENTS COVERED | Treatment Type, Administration Route, Indication, End User, Regional |
| KEY MARKET OPPORTUNITIES | Increasing prevalence of psoriasis, Growing demand for biologics, Expansion of telemedicine solutions, Advancements in personalized medicine, Rising awareness and education initiatives |
| KEY MARKET DYNAMICS | rising prevalence of psoriasis, increasing demand for biologics, advancements in treatment technologies, growing awareness and education, favorable reimbursement policies |
| COUNTRIES COVERED | North America, Europe, APAC, South America, MEA |
| Market Size 2024 | 19.12 |
| Market Size 2025 | 20.62 |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2035 |
Market Highlights
Author
Latest Comments
John Doe
john@example.com
This is a great article! Really helped me understand the topic better.
Posted on July 23, 2025, 10:15
AM
Jane Smith
jane@domain.com
Thanks for sharing this. I’ve bookmarked it for later reference.
Posted on July 22, 2025, 7:45
PM
FAQs
What is the expected market size for the Global Psoriasis Treatment Market in 2024?
The Global Psoriasis Treatment Market is expected to be valued at 7.45 USD Billion in 2024.
What is the anticipated market size for the Global Psoriasis Treatment Market by 2035?
By 2035, the market is projected to reach a value of 12.0 USD Billion.
What is the expected compound annual growth rate (CAGR) for the Global Psoriasis Treatment Market from 2025 to 2035?
The market is anticipated to grow at a CAGR of 4.43% from 2025 to 2035.
Which region holds the largest market share in the Global Psoriasis Treatment Market in 2024?
In 2024, North America is expected to hold the largest market share valued at 2.85 USD Billion.
What will the market value of Europe be in the Global Psoriasis Treatment Market by 2035?
The market value in Europe is projected to be 3.5 USD Billion by 2035.
What is the estimated market size for Biologics in the Global Psoriasis Treatment Market in 2024?
Biologics are expected to be valued at 2.65 USD Billion in 2024.
What opportunities exist in the Global Psoriasis Treatment Market for systemic treatments by 2035?
Systemic treatments are projected to grow to 3.0 USD Billion by 2035, indicating significant market opportunities.
Who are the key competitors in the Global Psoriasis Treatment Market?
Major players in the market include Pfizer, Merck and Co, AbbVie, and Johnson and Johnson among others.
What is the expected market value for Phototherapy in the Global Psoriasis Treatment Market in 2024?
Phototherapy is anticipated to be valued at 1.0 USD Billion in 2024.
What challenges does the Global Psoriasis Treatment Market face in growth?
The market faces challenges from regulatory hurdles and the high cost of development for new treatments.
-
--- "
-
Table of Contents
-
EXECUTIVE SUMMARY
-
Market Overview
-
Key Findings
-
Market Segmentation
-
Competitive Landscape
-
Challenges and Opportunities
-
Future Outlook
-
MARKET INTRODUCTION
-
Definition
-
Scope of the study
-
Research Objective
-
Assumption
-
Limitations
-
RESEARCH METHODOLOGY
-
Overview
-
Data Mining
-
Secondary Research
-
Primary Research
-
Primary Interviews and Information Gathering Process
-
Breakdown of Primary Respondents
-
Forecasting Model
-
Market Size Estimation
-
Bottom-Up Approach
-
Top-Down Approach
-
Data Triangulation
-
Validation
-
MARKET DYNAMICS
-
Overview
-
Drivers
-
Restraints
-
Opportunities
-
MARKET FACTOR ANALYSIS
-
Value chain Analysis
-
Porter's Five Forces Analysis
-
Bargaining Power of Suppliers
-
Bargaining Power of Buyers
-
Threat of New Entrants
-
Threat of Substitutes
-
Intensity of Rivalry
-
COVID-19 Impact Analysis
-
Market Impact Analysis
-
Regional Impact
-
Opportunity and Threat Analysis
-
Psoriasis Treatment Market, BY Treatment Type (USD Billion)
-
Topical Treatments
-
Systemic Treatments
-
Phototherapy
-
Biologics
-
Psoriasis Treatment Market, BY Administration Route (USD Billion)
-
Oral
-
Topical
-
Injectable
-
Intravenous
-
Psoriasis Treatment Market, BY Indication (USD Billion)
-
Plaque Psoriasis
-
Guttate Psoriasis
-
Inverse Psoriasis
-
Pustular Psoriasis
-
Psoriasis Treatment Market, BY End User (USD Billion)
-
Hospital
-
Dermatology Clinics
-
Homecare Settings
-
Psoriasis Treatment Market, BY Regional (USD Billion)
-
North America
-
US
-
Canada
-
Europe
-
Germany
-
UK
-
France
-
Russia
-
Italy
-
Spain
-
Rest of Europe
-
APAC
-
China
-
India
-
Japan
-
South Korea
-
Malaysia
-
Thailand
-
Indonesia
-
Rest of APAC
-
South America
-
Brazil
-
Mexico
-
Argentina
-
Rest of South America
-
MEA
-
GCC Countries
-
South Africa
-
Rest of MEA
-
Competitive Landscape
-
Overview
-
Competitive Analysis
-
Market share Analysis
-
Major Growth Strategy in the Psoriasis Treatment Market
-
Competitive Benchmarking
-
Leading Players in Terms of Number of Developments in the Psoriasis Treatment Market
-
Key developments and growth strategies
-
New Product Launch/Service Deployment
-
Merger & Acquisitions
-
Joint Ventures
-
Major Players Financial Matrix
-
Sales and Operating Income
-
Major Players R&D Expenditure. 2023
-
Company Profiles
-
Pfizer
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Merck and Co
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
AbbVie
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Johnson and Johnson
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Lilly
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
GSK
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
UCB
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Celgene
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Novartis
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Regeneron Pharmaceuticals
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
BristolMyers Squibb
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
AstraZeneca
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Amgen
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Eli Lilly and Company
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Sanofi
-
Financial Overview
-
Products Offered
-
Key Developments
-
SWOT Analysis
-
Key Strategies
-
Appendix
-
References
-
Related Reports
Psoriasis Treatment Market Segmentation
Psoriasis Treatment Market By Treatment Type (USD Billion, 2019-2035)
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
Psoriasis Treatment Market By Administration Route (USD Billion, 2019-2035)
Oral
Topical
Injectable
Intravenous
Psoriasis Treatment Market By Indication (USD Billion, 2019-2035)
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
Psoriasis Treatment Market By End User (USD Billion, 2019-2035)
Hospital
Dermatology Clinics
Homecare Settings
Psoriasis Treatment Market By Regional (USD Billion, 2019-2035)
North America
Europe
South America
Asia Pacific
Middle East and Africa
Psoriasis Treatment Market Regional Outlook (USD Billion, 2019-2035)
North America Outlook (USD Billion, 2019-2035)
North America Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
North America Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
North America Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
North America Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
North America Psoriasis Treatment Market by Regional Type
US
Canada
US Outlook (USD Billion, 2019-2035)
US Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
US Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
US Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
US Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
CANADA Outlook (USD Billion, 2019-2035)
CANADA Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
CANADA Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
CANADA Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
CANADA Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
Europe Outlook (USD Billion, 2019-2035)
Europe Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
Europe Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
Europe Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
Europe Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
Europe Psoriasis Treatment Market by Regional Type
Germany
UK
France
Russia
Italy
Spain
Rest of Europe
GERMANY Outlook (USD Billion, 2019-2035)
GERMANY Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
GERMANY Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
GERMANY Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
GERMANY Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
UK Outlook (USD Billion, 2019-2035)
UK Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
UK Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
UK Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
UK Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
FRANCE Outlook (USD Billion, 2019-2035)
FRANCE Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
FRANCE Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
FRANCE Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
FRANCE Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
RUSSIA Outlook (USD Billion, 2019-2035)
RUSSIA Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
RUSSIA Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
RUSSIA Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
RUSSIA Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
ITALY Outlook (USD Billion, 2019-2035)
ITALY Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
ITALY Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
ITALY Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
ITALY Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
SPAIN Outlook (USD Billion, 2019-2035)
SPAIN Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
SPAIN Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
SPAIN Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
SPAIN Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
REST OF EUROPE Outlook (USD Billion, 2019-2035)
REST OF EUROPE Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
REST OF EUROPE Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
REST OF EUROPE Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
REST OF EUROPE Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
APAC Outlook (USD Billion, 2019-2035)
APAC Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
APAC Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
APAC Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
APAC Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
APAC Psoriasis Treatment Market by Regional Type
China
India
Japan
South Korea
Malaysia
Thailand
Indonesia
Rest of APAC
CHINA Outlook (USD Billion, 2019-2035)
CHINA Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
CHINA Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
CHINA Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
CHINA Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
INDIA Outlook (USD Billion, 2019-2035)
INDIA Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
INDIA Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
INDIA Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
INDIA Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
JAPAN Outlook (USD Billion, 2019-2035)
JAPAN Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
JAPAN Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
JAPAN Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
JAPAN Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
SOUTH KOREA Outlook (USD Billion, 2019-2035)
SOUTH KOREA Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
SOUTH KOREA Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
SOUTH KOREA Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
SOUTH KOREA Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
MALAYSIA Outlook (USD Billion, 2019-2035)
MALAYSIA Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
MALAYSIA Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
MALAYSIA Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
MALAYSIA Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
THAILAND Outlook (USD Billion, 2019-2035)
THAILAND Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
THAILAND Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
THAILAND Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
THAILAND Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
INDONESIA Outlook (USD Billion, 2019-2035)
INDONESIA Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
INDONESIA Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
INDONESIA Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
INDONESIA Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
REST OF APAC Outlook (USD Billion, 2019-2035)
REST OF APAC Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
REST OF APAC Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
REST OF APAC Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
REST OF APAC Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
South America Outlook (USD Billion, 2019-2035)
South America Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
South America Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
South America Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
South America Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
South America Psoriasis Treatment Market by Regional Type
Brazil
Mexico
Argentina
Rest of South America
BRAZIL Outlook (USD Billion, 2019-2035)
BRAZIL Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
BRAZIL Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
BRAZIL Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
BRAZIL Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
MEXICO Outlook (USD Billion, 2019-2035)
MEXICO Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
MEXICO Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
MEXICO Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
MEXICO Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
ARGENTINA Outlook (USD Billion, 2019-2035)
ARGENTINA Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
ARGENTINA Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
ARGENTINA Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
ARGENTINA Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)
REST OF SOUTH AMERICA Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
REST OF SOUTH AMERICA Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
REST OF SOUTH AMERICA Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
REST OF SOUTH AMERICA Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
MEA Outlook (USD Billion, 2019-2035)
MEA Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
MEA Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
MEA Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
MEA Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
MEA Psoriasis Treatment Market by Regional Type
GCC Countries
South Africa
Rest of MEA
GCC COUNTRIES Outlook (USD Billion, 2019-2035)
GCC COUNTRIES Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
GCC COUNTRIES Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
GCC COUNTRIES Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
GCC COUNTRIES Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
SOUTH AFRICA Outlook (USD Billion, 2019-2035)
SOUTH AFRICA Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
SOUTH AFRICA Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
SOUTH AFRICA Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
SOUTH AFRICA Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
REST OF MEA Outlook (USD Billion, 2019-2035)
REST OF MEA Psoriasis Treatment Market by Treatment Type
Topical Treatments
Systemic Treatments
Phototherapy
Biologics
REST OF MEA Psoriasis Treatment Market by Administration Route Type
Oral
Topical
Injectable
Intravenous
REST OF MEA Psoriasis Treatment Market by Indication Type
Plaque Psoriasis
Guttate Psoriasis
Inverse Psoriasis
Pustular Psoriasis
REST OF MEA Psoriasis Treatment Market by End User Type
Hospital
Dermatology Clinics
Homecare Settings
Free Sample Request
Kindly complete the form below to receive a free sample of this Report
Customer Strories
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Leave a Comment